The most convincing study comes from a murine model of Barcena et al. The authors used both a genetic model of Axl deficiency (Axl KO) and a pharmacologic approach, the Axl inhibitor BGB324. Here, AXL is linked to hyperinsulinemic hypoglycemia, familial, 4.